Gina Lin
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- HIV/AIDS drug development and treatment 3
- HIV/AIDS Research and Interventions 2
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- Christopher Bruno (3 shared papers)Elizabeth G. Rhee (3 shared papers)Martin Nováček (2 shared papers)Richard G. Wunderink (2 shared papers)Nobuaki Shime (2 shared papers)Marin H. Kollef (2 shared papers)Álvaro Réa-Neto (2 shared papers)Ignacio Martín‐Loeches (2 shared papers)
- Journals
- Clinical Infectious Diseases (2 papers)Infectious Diseases (1 paper)Journal of Experimental Biology (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Experimental Brain Research (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Gina Lin
9 papers receiving 452 citations
Peers
Comparison fields: 5 of 59
- Applied Microbiology and Biotechnology 100
- Molecular Medicine 199
- Virology 104
- Critical Care and Intensive Care Medicine 73
- Infectious Diseases 165
Countries citing papers authored by Gina Lin
This map shows the geographic impact of Gina Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gina Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gina Lin more than expected).
Fields of papers citing papers by Gina Lin
This network shows the impact of papers produced by Gina Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gina Lin. The network helps show where Gina Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Gina Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 230 | |
| 2 | 2018 | 107 | |
| 3 | 2020 | 44 | |
| 4 | 2007 | 27 | |
| 5 | 2015 | 20 | |
| 6 | 2021 | 15 | |
| 7 | 2018 | 9 | |
| 8 | 2022 | 5 | |
| 9 | 2025 | 1 | |
| 10 | 2019 | 0 |
About Gina Lin
Gina Lin is a scholar working on Infectious Diseases, Pharmacology, Virology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 10 papers that have together received 458 indexed citations. Recurring topics across this work include HIV Research and Treatment (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), HIV/AIDS drug development and treatment (3 papers), Antibiotic Resistance in Bacteria (3 papers), Nosocomial Infections in ICU (2 papers), HIV/AIDS Research and Interventions (2 papers), Pneumonia and Respiratory Infections (2 papers) and Animal Nutrition and Physiology (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (100 citations), Molecular Medicine (199 citations), Virology (104 citations), Critical Care and Intensive Care Medicine (73 citations) and Infectious Diseases (165 citations). Gina Lin has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Christopher Bruno, Elizabeth G. Rhee, Martin Nováček, Richard G. Wunderink, Nobuaki Shime, Marin H. Kollef, Álvaro Réa-Neto, Ignacio Martín‐Loeches, Joan R. Butterton and Jennifer A. Huntington. Their work appears in journals such as Clinical Infectious Diseases, Infectious Diseases, Journal of Experimental Biology, Antimicrobial Agents and Chemotherapy and Experimental Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.